2010•The Journal of Clinical PsychiatryRequires access

Fluvoxamine in treating depressive disorder with anxiety

Q. Zhang

Open publisher page 0 citations

Abstract

Objective:To compare the clinical effects and adverse reactions of fluvoxamine and fluoxetine in treatment of depression with anxiety. Method:71 patients with depression with anxiety were randomized into either fluvoxamine group (n=36) or fluoxetine group (n=35) for 8 weeks. Hamilton depressive scale (HAMD),Hamilton anxiety scale (HAMA) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects. Results:The HAMD and HAMA score of both groups decreased significantly compared with those before treatment (all P0.01).The significant decrease was showed in fluvoxamine group after 1week treatment but in fluoxetine group after 2 weeks treatment(P0.01).There were significant differences between the two groups(P0.05 or P0.01).The overall adverse reactions in both groups showed no significant difference. Conclusion:Fluvoxamine and fluoxetine are equally safe and effective drug in treatment of depression with anxiety,but fluvoxamine may act more rapidly than fluoxetine.

About this research paper

What this paper is about

Objective:To compare the clinical effects and adverse reactions of fluvoxamine and fluoxetine in treatment of depression with anxiety. Method:71 patients with depression with anxiety were randomized into either fluvoxamine group (n=36) or fluoxetine group (n=35) for 8 weeks. Hamilton depressive scale (HAMD),Hamilton anxiety scale (HAMA) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects. Results:The HAMD and HAMA score of both groups decreased significantly compared with those before treatment (all P0.01).The significant decrease was showed in fluvoxamine group after 1week treatment but in fluoxetine group after 2 weeks treatment(P0.01).There were significant differences between the two groups(P0.05 or P0.01).The overall adverse reactions in both groups showed no significant difference. Conclusion:Fluvoxamine and fluoxetine are equally safe and effective drug in treatment of depression with anxiety,but fluvoxamine may act more rapidly than fluoxetine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare the clinical effects and adverse reactions of fluvoxamine and fluoxetine in treatment of depression with anxiety. Method:71 patients with depression with anxiety were randomized into either fluvoxamine group (n=36) or fluoxetine group (n=35) for 8 weeks. Hamilton depressive scale (HAMD),Hamilton anxiety scale (HAMA) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects. Results:The HAMD and HAMA score of both groups decreased significantly compared with those before treatment (all P0.01).The significant decrease was showed in fluvoxamine group after 1week treatment but in fluoxetine group after 2 weeks treatment(P0.01).There were significant differences between the two groups(P0.05 or P0.01).The overall adverse reactions in both groups showed no significant difference. Conclusion:Fluvoxamine and fluoxetine are equally safe and effective drug in treatment of depression with anxiety,but fluvoxamine may act more rapidly than fluoxetine.

Key concepts: Fluvoxamine, Hamd, Fluoxetine, Anxiety, Psychology, Depression (economics), Hamilton Rating Scale for Depression, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Fluvoxamine in treating depressive disorder with anxiety — Research Paper | ScholarLens